← Back to Search

Behavioural Intervention

Yoga for Cancer-Related Stress

N/A
Recruiting
Led By Kathryn Glaser
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have been diagnosed with a cancer and have finished treatment
Age >= 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months post-intervention
Awards & highlights

Study Summary

This trial looks at whether yoga can help improve stress levels in cancer survivors. The yoga intervention being tested includes both restorative poses, breathing techniques, and guided meditation.

Who is the study for?
This trial is for cancer survivors who are 18 or older, have finished treatment, and been cleared for physical activity by a healthcare provider. They must understand the study and agree to its terms. It's not for those unable to follow the protocol, pregnant or nursing individuals, people with skeletal/cardio-pulmonary issues, or if English assessments can't be completed.Check my eligibility
What is being tested?
The trial is testing an online hatha yoga program designed to reduce stress in cancer survivors. The program includes restorative poses, breathing exercises, guided meditation and aims to improve overall health quality.See study design
What are the potential side effects?
Since this intervention involves gentle yoga practices tailored for cancer survivors, side effects may include typical exercise-related risks such as muscle strains but should generally be minimal given proper supervision and adherence to individual capabilities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have completed my cancer treatment.
Select...
I am 18 years old or older.
Select...
I have been cleared for physical activity by a healthcare professional.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of subjects who participate or show high adherence to the intervention
Secondary outcome measures
Efficacy of the intervention in stress reduction
Efficacy of the intervention in stress-reduction
Other outcome measures
Change in Cognitive function
Change in Quality of life

Side effects data

From 2022 Phase 3 trial • 87 Patients • NCT02066181
73%
Fatigue
71%
Palmar-plantar erythrodysesthesia syndrome
63%
Hypertension
61%
Papulopustular rash
55%
Diarrhea
51%
Nausea
39%
Myalgia
37%
Alopecia
35%
Arthralgia
33%
Abdominal pain
31%
Anorexia
27%
Vomiting
22%
Mucositis oral
22%
Constipation
18%
Anemia
18%
Alanine aminotransferase increased
16%
Platelet count decreased
14%
Pruritus
14%
Hyperglycemia
14%
Rash maculo-papular
14%
Skin and subcutaneous tissue disorders - Other, specify
12%
Aspartate aminotransferase increased
12%
Rash acneiform
12%
Peripheral sensory neuropathy
10%
Investigations - Other, specify
10%
Dry skin
10%
Neutrophil count decreased
10%
Blood bilirubin increased
8%
Back pain
8%
Headache
8%
Nervous system disorders - Other, specify
8%
Pain in extremity
6%
General disorders and administration site conditions - Other, specify
6%
Skin infection
6%
White blood cell decreased
6%
Hypercalcemia
6%
Hypokalemia
6%
Musculoskeletal and connective tissue disorder - Other, specify
6%
Dizziness
6%
Respiratory, thoracic and mediastinal disorders - Other, specify
6%
Eye disorders - Other, specify
6%
Hyperkalemia
6%
Pain
6%
Alkaline phosphatase increased
6%
Hypocalcemia
6%
Cough
4%
Flushing
4%
Tinnitus
4%
Dental caries
4%
Gastrointestinal disorders - Other, specify
4%
Hemoglobin increased
4%
Weight loss
4%
Metabolism and nutrition disorders - Other, specify
4%
Dysgeusia
4%
Anxiety
4%
Irregular menstruation
4%
Menorrhagia
4%
Sore throat
4%
Lymphocyte count decreased
4%
Hyperuricemia
4%
Non-cardiac chest pain
4%
Infections and infestations - Other, specify
4%
Hypernatremia
4%
Hypoglycemia
4%
Scalp pain
4%
Dry mouth
2%
Acute kidney injury
2%
Hypothyroidism
2%
Hemorrhoids
2%
Blurred vision
2%
Palpitations
2%
Leukocytosis
2%
Myocardial infarction
2%
Vertigo
2%
Anal hemorrhage
2%
Dysphagia
2%
Esophageal pain
2%
Periodontal disease
2%
Fever
2%
Sinusitis
2%
Urinary tract infection
2%
Bruising
2%
Dermatitis radiation
2%
Cholesterol high
2%
Creatinine increased
2%
Neck pain
2%
Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
2%
Concentration impairment
2%
Memory impairment
2%
Spasticity
2%
Depression
2%
Insomnia
2%
Allergic rhinitis
2%
Productive cough
2%
Sleep apnea
2%
Pregnancy, puerperium and perinatal conditions - Other, specify
2%
Dry eye
2%
Lymphedema
2%
Chest pain - cardiac
2%
Heart failure
2%
Gastric perforation
2%
Hypertriglyceridemia
2%
Dyspnea
2%
Cardiac disorders - Other, specify
2%
Gastroesophageal reflux disease
2%
Oral dysesthesia
2%
Chills
2%
Hypophosphatemia
2%
Chest wall pain
2%
Psychiatric disorders - Other, specify
2%
Hematuria
2%
Urinary tract obstruction
2%
Dysmenorrhea
2%
Skin hypopigmentation
2%
Urticaria
2%
Unintended pregnancy
2%
Flu like symptoms
2%
Nail infection
2%
Pancreatitis
2%
Blood and lymphatic system disorders - Other, specify
2%
Oral pain
2%
Fall
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (Sorafenib Tosylate)
Arm II (Placebo)
Crossover Group

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (yoga)Experimental Treatment3 Interventions
Patients receive online yoga intervention QW for 12 weeks.

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
400 Previous Clinical Trials
30,769 Total Patients Enrolled
Kathryn GlaserPrincipal InvestigatorRoswell Park Cancer Institute

Media Library

Yoga Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04754529 — N/A
Blood Cancers Research Study Groups: Supportive care (yoga)
Blood Cancers Clinical Trial 2023: Yoga Intervention Highlights & Side Effects. Trial Name: NCT04754529 — N/A
Yoga Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04754529 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate figure of participants enrolled in this clinical trial?

"Affirmative. Clinicaltrials.gov's archives mark this trial as underway with recruitment beginning on November 8th 2021 and the last update to the page occurring April 25, 2022. The study needs 30 volunteers from a single site for participation."

Answered by AI

Are there any spots open for individuals to join this clinical trial?

"Affirmative. Clinicaltrials.gov data suggests that recruitment for this medical study is still ongoing; it was initially posted on November 8th, 2021 and last updated April 25th 2022. A total of 30 patients are required from a single trial site."

Answered by AI
~0 spots leftby Apr 2024